The maker of a smartphone breathalyzer violated federal advertising rules when it promised that its products offered “government lab-grade testing” to measure consumers’ blood-alcohol concentration. The CEO of the company agreed to settle with the Federal Trade Commission, which alleged the firm didn’t have the proper scientific evidence to back…
Updated: